XML 53 R35.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Stock Based Compensation | Schedule of Stock Based Compensation
|  | 2024 |  |  | 2023 |
Cost of revenue |  | $ | 152 |  |  | $ | 120 |
Research and development |  |  | 188 |  |  |  | 159 |
Selling |  |  | 107 |  |  |  | 94 |
General and administrative |  |  | 616 |  |  |  | 535 |
Total stock-based compensation expense |  | $ | 1,063 |  |  | $ | 908 |
Schedule of Weighted Average Assumptions | Schedule of Weighted Average Assumptions
Stock price |  | $ | 4.75 |
Exercise price |  | $ | 4.75 |
Dividend yield |  |  | 0 | %
Expected volatility |  |  | 77 | %
Risk-free interest rate |  |  | 4.12 | %
Expected life (in years) |  |  | 6.00 |
Schedule of Stock Options Awards | The following table summarizes stock options awards for the years ended December 31, 2024 and 2023: Schedule of Stock Options Awards
|  |  |  |  | Weighted |
|  | Awards (in Shares) |  |  | Average Exercise Price |
Outstanding at December 31, 2022 |  |  | 673,000 |  |  | $ | 11.26 |
Granted |  |  | 254,000 |  |  |  | 14.02 |
Expired / cancelled |  |  | (44,500 | ) |  |  | 6.57 |
Exercised |  |  | (35,625 | ) |  |  | 4.53 |
Outstanding at December 31, 2023 |  |  | 846,875 |  |  |  | 8.20 |
Granted |  |  | 5,000 |  |  |  | 4.75 |
Expired / cancelled |  |  | (28,750 | ) |  |  | 7.94 |
Exercised |  |  | - |  |  |  | - |
Outstanding at December 31, 2024 |  |  | 823,125 |  |  |  | 8.24 |
Schedule of Outstanding and Exercisable Options Ranges of Exercise Prices | The following table summarizes information about the outstanding and exercisable options at December 31, 2024: Schedule of Outstanding and Exercisable Options Ranges of Exercise Prices
|  |  | Options Outstanding |  |  | Options Exercisable |
|  |  |  |  |  | Weighted |  |  | Weighted |  |  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  |  | Average |  |  | Average |  |  |  |  |  |  |  |  | Average |  |  |  |
Exercise |  |  | Number |  |  | Remaining |  |  | Exercise |  |  | Intrinsic |  |  | Number |  |  | Exercise |  |  | Intrinsic |
Price Range |  |  | Outstanding |  |  | Contractual |  |  | Price |  |  | Value |  |  | Exercisable |  |  | Price |  |  | Value |
$ | 4.00-7.00 |  |  |  | 444,625 |  |  |  | 6.7 |  |  | $ | 4.39 |  |  | $ | - |  |  |  | 285,375 |  |  | $ | 5.86 |  |  | $ | 50,580 |
$ | 7.01-10.00 |  |  |  | 20,000 |  |  |  | 3.3 |  |  | $ | 8.07 |  |  | $ | - |  |  |  | 20,000 |  |  | $ | 8.07 |  |  | $ | - |
$ | 10.01-13.00 |  |  |  | 130,000 |  |  |  | 2.7 |  |  | $ | 10.62 |  |  | $ | - |  |  |  | 122,500 |  |  | $ | 10.55 |  |  | $ | - |
$ | 13.01-16.00 |  |  |  | 228,500 |  |  |  | 8.2 |  |  | $ | 14.11 |  |  | $ | - |  |  |  | 57,125 |  |  | $ | 14.11 |  |  | $ | - |
Schedule of Restricted Stock Awards | The following table summarizes restricted stock awards for the years ended December 31, 2024 and 2023: Schedule of Restricted Stock Awards
|  |  |  |  | Weighted |
|  |  |  |  | Average Grant |
|  | Shares of |  |  | Date Fair |
|  | Restricted Stock |  |  | Value |
Unvested outstanding at January 1, 2023 |  |  | - |  |  | $ | - |
Granted |  |  | 41,320 |  |  |  | 6.65 |
Vested |  |  | (24,187 | ) |  |  | 6.81 |
Forfeited or cancelled |  |  | - |  |  |  | - |
Unvested outstanding at December 31, 2023 |  |  | 17,133 |  |  |  | 6.53 |
Granted |  |  | 57,327 |  |  |  | 3.55 |
Vested |  |  | (46,210 | ) |  |  | 4.63 |
Forfeited or cancelled |  |  | - |  |  |  | - |
Unvested outstanding at December 31, 2024 |  |  | 28,250 |  |  | $ | 3.54 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration